These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

95 related articles for article (PubMed ID: 1105698)

  • 1. Treatment with reserpine of patients resistant to tricyclic antidepressants. A double-blind trial.
    Hopkinson G; Kenny F
    Psychiatr Clin (Basel); 1975; 8(3):109-14. PubMed ID: 1105698
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Treatment of refractory depression with combination reserpine and tricyclic antidepressant therapy.
    Amsterdam JD; Berwish N
    J Clin Psychopharmacol; 1987 Aug; 7(4):238-42. PubMed ID: 3305592
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Fluoxetine and suicide: a meta-analysis of controlled trials of treatment for depression.
    Beasley CM; Dornseif BE; Bosomworth JC; Sayler ME; Rampey AH; Heiligenstein JH; Thompson VL; Murphy DJ; Masica DN
    BMJ; 1991 Sep; 303(6804):685-92. PubMed ID: 1833012
    [TBL] [Abstract][Full Text] [Related]  

  • 4. A meta-analysis of eight randomized, double-blind, controlled clinical trials of mirtazapine for the treatment of patients with major depression and symptoms of anxiety.
    Fawcett J; Barkin RL
    J Clin Psychiatry; 1998 Mar; 59(3):123-7. PubMed ID: 9541155
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Reserpine added to neuroleptic-tricyclic in refractory schizophrenics.
    Bacher N; Lewis H
    J Clin Psychiatry; 1981 Aug; 42(8):326. PubMed ID: 7019202
    [No Abstract]   [Full Text] [Related]  

  • 6. [Double-blind comparison of the effects of a new tricyclic antidepressant (Lofepramine) and a tetracyclic antidepressant (maprotiline)].
    Obermair W; Pöldinger W
    Int Pharmacopsychiatry; 1977; 12(2):65-71. PubMed ID: 330440
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Tricyclic antidepressive treatment reinforced by reserpine.
    Moscovich D; Mester R
    Isr J Psychiatry Relat Sci; 1984; 21(4):283-9. PubMed ID: 6537431
    [No Abstract]   [Full Text] [Related]  

  • 8. Double-blind clinical trial of the antidepressant action of amineptine.
    van Amerongen P
    Curr Med Res Opin; 1979; 6(2):93-100. PubMed ID: 380915
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Treatment of endogenous depressions resistant to tricyclic antidepressants or related drugs by lithium addition. Results of a placebo-controlled double-blind study.
    Schöpf J; Baumann P; Lemarchand T; Rey M
    Pharmacopsychiatry; 1989 Sep; 22(5):183-7. PubMed ID: 2682692
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Double-blind comparative study on the effects of lofepramine and amitriptyline in depressive outpatients (author's transl)].
    Wright S; Herrmann L
    Arzneimittelforschung; 1976; 26(6):1167-9. PubMed ID: 786313
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Open trial and double-blind clinical trial of the antidepressant Ro 8-1998 in comparison with imipramine.
    Woggon B; Angst J
    Int Pharmacopsychiatry; 1977; 12(1):38-48. PubMed ID: 873718
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The effect of diazepam on the recovery of endogenously depressed patients.
    Bowen RC
    J Clin Pharmacol; 1978; 18(5-6):280-4. PubMed ID: 346617
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Estrogen therapy for severe persistent depressions in women.
    Klaiber EL; Broverman DM; Vogel W; Kobayashi Y
    Arch Gen Psychiatry; 1979 May; 36(5):550-4. PubMed ID: 219802
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Reserpine augmentation of desipramine in refractory depression: clinical and neurobiological effects.
    Price LH; Charney DS; Heninger GR
    Psychopharmacology (Berl); 1987; 92(4):431-7. PubMed ID: 2442788
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Multicenter double-blind randomized parallel-group clinical trial of efficacy of the combination clomipramine (150 mg/day) plus lithium carbonate (750 mg/day) versus clomipramine (150 mg/day) plus placebo in the treatment of unipolar major depression.
    Januel D; Poirier MF; D'alche-Biree F; Dib M; Olié JP
    J Affect Disord; 2003 Sep; 76(1-3):191-200. PubMed ID: 12943949
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Imipramine is effective in preventing relapse in electroconvulsive therapy-responsive depressed inpatients with prior pharmacotherapy treatment failure: a randomized, placebo-controlled trial.
    van den Broek WW; Birkenhäger TK; Mulder PG; Bruijn JA; Moleman P
    J Clin Psychiatry; 2006 Feb; 67(2):263-8. PubMed ID: 16566622
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Fluoxetine, placebo, and tricyclic antidepressants in major depression with and without anxious features.
    Tollefson GD; Holman SL; Sayler ME; Potvin JH
    J Clin Psychiatry; 1994 Feb; 55(2):50-9. PubMed ID: 8077155
    [TBL] [Abstract][Full Text] [Related]  

  • 18. A randomized, controlled trial of amitriptyline in the acute treatment of adolescent major depression.
    Kye CH; Waterman GS; Ryan ND; Birmaher B; Williamson DE; Iyengar S; Dachille S
    J Am Acad Child Adolesc Psychiatry; 1996 Sep; 35(9):1139-44. PubMed ID: 8824057
    [TBL] [Abstract][Full Text] [Related]  

  • 19. L-tryptophan in depression.
    Farkas T; Dunner DL; Fieve RR
    Biol Psychiatry; 1976 Jun; 11(3):295-302. PubMed ID: 779855
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Verapamil is not an antidepressant in patients resistant to tricyclic antidepressants.
    Adlersberg S; Toren P; Mester R; Rehavi M; Skolnick P; Weizman A
    Clin Neuropharmacol; 1994 Jun; 17(3):294-7. PubMed ID: 9316675
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.